Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Musa

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Plos Genetics|May 16, 2007
Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in SudanE Nancy Miller, Manal Fadl, Hiba S Mohamed, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 16, 2005
Uncommon clinical presentations of cutaneous leishmaniasis in SudanE M Elamin, S Guerbouj, A M Musa, et al.
The Journal of Infectious Diseases|August 21, 2024
Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern AfricaWan-Yu Chu, Luka Verrest, Brima M Younis, et al.
Journal of Family Medicine and Primary Care|August 30, 2019
Vitamin D level and its determinants among Sudanese Women: Does it matter in a sunshine African Country?Nazik Elmalaika Husain, Ahmed Abdel Badie Suliman, Ismail Abdelrahman, et al.
Clinical and Experimental Immunology|April 6, 2005
Dichotomy of protective cellular immune responses to human visceral leishmaniasisE A G Khalil, N B Ayed, A M Musa, et al.
Global Heart|October 23, 2023
Prevalence and Determinants of Endothelial Dysfunction among Adults Living with HIV in Northwest NigeriaAisha M Nalado, Bala Waziri, Anas Ismail, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 7, 2026
Safety and tolerability of the ACE-inhibitor lisinopril among Nigerian adults with HIV: preliminary pilot data from a randomized clinical trialFaisal S Dankishiya, Hamza Muhammad, Usman J Wudil, et al.
West African Journal of Medicine|November 14, 2024
A PROTOCOL FOR ACCELERATING THE ADOPTION OF EVIDENCE-BASED MATERNAL, NEWBORN, CHILD, AND NUTRITION HEALTH (MNCNH) INNOVATIONS TO REDUCE MATERNAL MORTALITY IN NIGERIAR N Ogu, H Galadanci, O Maduka, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic studyThomas P C Dorlo, Anke E Kip, Brima M Younis, et al.
Clinical Rheumatology|May 6, 2018
Running does not increase symptoms or structural progression in people with knee osteoarthritis: data from the osteoarthritis initiativeGrace H Lo, Sarra M Musa, Jeffrey B Driban, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Plos Genetics|May 16, 2007
Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in SudanE Nancy Miller, Manal Fadl, Hiba S Mohamed, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 16, 2005
Uncommon clinical presentations of cutaneous leishmaniasis in SudanE M Elamin, S Guerbouj, A M Musa, et al.
The Journal of Infectious Diseases|August 21, 2024
Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern AfricaWan-Yu Chu, Luka Verrest, Brima M Younis, et al.
Journal of Family Medicine and Primary Care|August 30, 2019
Vitamin D level and its determinants among Sudanese Women: Does it matter in a sunshine African Country?Nazik Elmalaika Husain, Ahmed Abdel Badie Suliman, Ismail Abdelrahman, et al.
Clinical and Experimental Immunology|April 6, 2005
Dichotomy of protective cellular immune responses to human visceral leishmaniasisE A G Khalil, N B Ayed, A M Musa, et al.
Global Heart|October 23, 2023
Prevalence and Determinants of Endothelial Dysfunction among Adults Living with HIV in Northwest NigeriaAisha M Nalado, Bala Waziri, Anas Ismail, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 7, 2026
Safety and tolerability of the ACE-inhibitor lisinopril among Nigerian adults with HIV: preliminary pilot data from a randomized clinical trialFaisal S Dankishiya, Hamza Muhammad, Usman J Wudil, et al.
West African Journal of Medicine|November 14, 2024
A PROTOCOL FOR ACCELERATING THE ADOPTION OF EVIDENCE-BASED MATERNAL, NEWBORN, CHILD, AND NUTRITION HEALTH (MNCNH) INNOVATIONS TO REDUCE MATERNAL MORTALITY IN NIGERIAR N Ogu, H Galadanci, O Maduka, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic studyThomas P C Dorlo, Anke E Kip, Brima M Younis, et al.
Clinical Rheumatology|May 6, 2018
Running does not increase symptoms or structural progression in people with knee osteoarthritis: data from the osteoarthritis initiativeGrace H Lo, Sarra M Musa, Jeffrey B Driban, et al.
Pageof 26